Consistently, the GEPIA web tool analysis demonstrated that FGD1 mRNA expression was also positively correlated with PD-L1 mRNA in various types of tumors, including sarcoma, prostate cancer, pancreatic cancer, esophagus cancer, bladder cancer and melanoma (Figure S6A). Here, FGD1 is linked to urinary bladder cancer.